CCXI
ChemoCentryx, Inc.
NasdaqGS
People also watch:CLRBCEMPVSTMRGLSINFI
4.63-0.05 (-1.07%)

After hours: 4.630.00 (0.00%) as of 4:44 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close4.68
Open4.66
Bid2.76 x 600
Ask5.00 x 2500
52wk Range1.92 - 8.78
Day's Range4.57 - 4.70
Volume57,791
Avg Vol (3m)1,381,433
As of 4:00 PM EDT. Market closed.
  • ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
    Capital Cube2 months ago

    ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016

    Click here to see latest analysisChemoCentryx, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -15.24 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.CCXI-US‘s earnings and EBITDA are both […] (Read more...) The post ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.

  • Market Realist2 months ago

    IBB Rose 0.9% before the Long Weekend

    The iShares Nasdaq Biotechnology ETF (IBB) outperformed the Market, rising 0.9% before the long weekend.